Published in Am J Physiol on July 01, 1984
Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest (2004) 1.31
Pharmacokinetics of epinephrine in patients with septic shock: modelization and interaction with endogenous neurohormonal status. Crit Care (2009) 0.89
Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: a pilot, randomized controlled study. Evid Based Complement Alternat Med (2014) 0.83
Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study. J Transl Med (2016) 0.77
The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress. Br J Clin Pharmacol (2004) 0.77
Elevated plasma norepinephrine after in utero exposure to cocaine and marijuana. Pediatrics (1997) 0.77
Plasma catecholamines and hyperglycaemia influence thermoregulation in man during prolonged exercise in the heat. J Physiol (1996) 0.77
Effects of low-dose clonidine on cardiovascular and autonomic variables in adolescents with chronic fatigue: a randomized controlled trial. BMC Pediatr (2015) 0.76
Influence of circulating alpha adrenoceptor agonists on lung function in patients with exercise induced asthma and healthy subjects. Thorax (1986) 0.75
A new spectrophotometric method for the determination of methyldopa. Saudi Pharm J (2009) 0.75
Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis. Gut (1999) 0.75
Effects of long-term dietary restriction on cardiovascular function and plasma catecholamines in the rat. Cardiovasc Drugs Ther (1996) 0.75
Monitoring the Secretory Behavior of the Rat Adrenal Medulla by High-Performance Liquid Chromatography-Based Catecholamine Assay from Slice Supernatants. Front Endocrinol (Lausanne) (2017) 0.75
Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci (1979) 1.80
Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J (2001) 1.79
Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis (1997) 1.63
Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci (Lond) (1999) 1.63
Importance of creatinine analyses of urine when screening for abused drugs. Clin Chem (1991) 1.60
Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. Eur Heart J (1999) 1.57
Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS). Eur Heart J (2000) 1.53
Psychosocial variables in female vs male patients with stable angina pectoris and matched healthy controls. Eur Heart J (1997) 1.47
Ischaemia during exercise and ambulatory monitoring in patients with stable angina pectoris and healthy controls. Gender differences and relationships to catecholamines. Eur Heart J (1998) 1.46
Comparison of subcutaneous injection and high-dose inhalation of epinephrine--implications for self-treatment to prevent anaphylaxis. J Allergy Clin Immunol (1986) 1.45
Flow dependence of forearm noradrenaline overflow, as assessed during mental stress and sodium nitroprusside infusion. J Hypertens (1999) 1.39
[Randomization and ethics. Patient participation is a serious demand in medical research]. Lakartidningen (1992) 1.38
Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? J Hypertens (1992) 1.36
The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia (1992) 1.26
Fetal and maternal plasma catecholamine levels at elective cesarean section under general or epidural anesthesia versus vaginal delivery. Am J Obstet Gynecol (1982) 1.21
Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) Eur Heart J (1996) 1.09
Rebound phenomena following gradual withdrawal of chronic metoprolol treatment in patients with ischemic heart disease. Am Heart J (1984) 1.08
Differentiated sympathetic activation during mental stress evoked by the Stroop test. Acta Physiol Scand Suppl (1984) 1.08
Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation (1999) 1.06
Sustained forearm vasodilation in humans during mental stress is not neurogenically mediated. Acta Physiol Scand (1996) 1.06
Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners. Eur J Clin Pharmacol (2001) 1.04
Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun (1985) 1.03
Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol (2000) 1.02
Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes. Br J Clin Pharmacol (1989) 1.01
Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. Methods Enzymol (1987) 1.01
Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. Eur Heart J (1997) 1.01
Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. Hypertension (1983) 0.99
Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol (1986) 0.98
Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometry. Clin Sci (Lond) (1989) 0.97
Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol Scand Suppl (1983) 0.96
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation (1994) 0.95
Cardiovascular and sympathoadrenal responses to mental stress: influence of beta-blockade. Am J Physiol (1988) 0.95
Sympathoadrenal and cardiovascular responses to mental stress, isometric handgrip, and cold pressor test in asymptomatic young men with primary T wave abnormalities in the electrocardiogram. Br Heart J (1981) 0.94
Muscle sympathetic activity and venous plasma noradrenaline concentrations during static exercise in normotensive and hypertensive subjects. Acta Physiol Scand (1987) 0.93
Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. Atherosclerosis (2000) 0.93
A comparison of sympathoadrenal activity and cardiac performance at rest and during exercise in patients with ventricular demand or atrial synchronous pacing. Br Heart J (1988) 0.93
Studies in vivo and in vitro of terbutaline-induced beta-adrenoceptor desensitization in healthy subjects. Clin Sci (Lond) (1987) 0.93
Adipose tissue and skeletal muscle blood flow during mental stress. Am J Physiol (1989) 0.93
Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate. Thromb Haemost (2013) 0.93
Vascular and metabolic effects of circulating epinephrine and norepinephrine. Concentration-effect study in dogs. J Clin Invest (1979) 0.92
Renal responses to mental stress and epinephrine in humans. Am J Physiol (1989) 0.92
Cardiovascular and sympathoadrenal responses to mental stress: a study of sensory intake and rejection reactions. Acta Physiol Scand (1990) 0.91
Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris. Heart (2002) 0.90
On the accurate determination of serotonin in human plasma. Biochem Biophys Res Commun (1993) 0.90
Effects of mental and physical stress on central haemodynamics and cardiac sympathetic nerve activity during QT interval-sensing rate-responsive and fixed rate ventricular inhibited pacing. Eur Heart J (1990) 0.89
Bronchodilatation and inhibition of allergen-induced bronchoconstriction by circulating epinephrine in asthmatic subjects. J Allergy Clin Immunol (1985) 0.89
Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension. Clin Physiol (1985) 0.89
Influence of circulating NE and Epi on adipose tissue vascular resistance and lipolysis in humans. Am J Physiol (1983) 0.89
Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine. Acta Physiol Scand (1984) 0.89
Renal neurohormonal and vascular responses to dynamic exercise in humans. J Appl Physiol (1985) (1991) 0.88
Analysis of phenylephrine in plasma: initial data about the concentration-effect relationship. Eur J Clin Pharmacol (1986) 0.88
Sympathoadrenal reactivity in exercise-induced asthma. Chest (1982) 0.88
Further studies on renal nerve stimulation induced release of noradrenaline and dopamine from the canine kidney in situ. Acta Physiol Scand (1984) 0.88
Cardiovascular and sympatho-adrenal responses to mental stress in primary hypertension. Clin Sci (Lond) (1993) 0.88
Cardiovascular and metabolic responses to low dose adrenaline infusion: an invasive study in humans. Clin Sci (Lond) (1986) 0.88
Is DDD pacing superior to VVI,R? A study on cardiac sympathetic nerve activity and myocardial oxygen consumption at rest and during exercise. Pacing Clin Electrophysiol (1992) 0.87
Epinephrine-induced changes in muscle carbohydrate metabolism during exercise in male subjects. J Appl Physiol (1985) (1986) 0.87
Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm. Circulation (1997) 0.87
Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release. Am J Physiol (1989) 0.86
Forearm vasodilator mechanisms during mental stress: possible roles for epinephrine and ANP. Am J Physiol (1996) 0.86
Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy. J Thromb Haemost (2004) 0.86
Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide. Diabet Med (2006) 0.85
Comparison of urinary and plasma catecholamine responses to mental stress. Acta Physiol Scand (1983) 0.85
Circulatory and sympatho-adrenal responses to stress in borderline and established hypertension. J Hypertens (1983) 0.85
Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry (1999) 0.85
Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. Am J Cardiol (1995) 0.84
Influence of metoprolol treatment on sympatho-adrenal activation of fibrinolysis. Thromb Haemost (1990) 0.84
Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle. Acta Physiol Scand (1984) 0.84
Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia. Thromb Haemost (1998) 0.84
Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation. Atherosclerosis (1998) 0.84
Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients. Psychopharmacology (Berl) (1995) 0.84
Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle. Acta Physiol Scand (1988) 0.83
Attenuation of forearm vasodilator responses to mental stress by regional beta-blockade, but not by atropine. Acta Physiol Scand (1997) 0.83
Anti-aggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometry. Clin Sci (Lond) (1991) 0.83
The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris. Diabet Med (2005) 0.83
On the accurate measurement of serotonin in whole blood. Scand J Clin Lab Invest (1998) 0.83
Does cardiovascular reactivity to mental stress have prognostic value in postinfarction patients? A pilot study. Psychosom Med (1992) 0.83
Inhibition by acidosis of adenosine 3',5'-cyclic monophosphate accumulation and lipolysis in isolated rat fat cells. Acta Physiol Scand (1976) 0.82
Sympathoadrenal and cardiovascular reactivity in pregnancy-induced hypertension. II. Responses to tilting. Am J Obstet Gynecol (1985) 0.82
Adrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasma. J Hypertens (1989) 0.82
Sympatho-adrenal and cardiovascular reactivity in pregnancy-induced hypertension. I. Responses to isometric exercise and a cold pressor test. Br J Obstet Gynaecol (1985) 0.82
Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment. Psychopharmacology (Berl) (1999) 0.82
Multi-cellular activation in vivo by endotoxin in humans--limited protection by adenosine infusion. Thromb Haemost (2000) 0.82
Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional alpha- and beta-adrenoceptors in vivo. Br J Pharmacol (1988) 0.81
Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade. Circulation (1991) 0.81
Improvement of the isoprenaline infusion test by plasma concentration measurements. Life Sci (1986) 0.81
Reduced beta 2-adrenoceptor responsiveness in exercise-induced asthma. Chest (1985) 0.81
Comparison of the lipolytic activity of circulating and locally released noradrenaline during acidosis. Acta Physiol Scand (1974) 0.81
Renal responses to lower body negative pressure in humans. Am J Physiol (1990) 0.81
Effect of tilting on adipose tissue vascular resistance and sympathetic activity in humans. Am J Physiol (1982) 0.81
Effects of selective LDL-apheresis and pravastatin therapy on platelet function in familial hypercholesterolaemia. Eur J Clin Invest (1994) 0.81
Metabolic effects of blood flow restriction in adipose tissue. Acta Physiol Scand (1979) 0.81
Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms. Am J Physiol (1993) 0.81
Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid. Eur Heart J (1998) 0.81
Sympathoadrenal responses to bronchoconstriction in asthma: an invasive and kinetic study of plasma catecholamines. Clin Sci (Lond) (1995) 0.81
Platelet-lymphocyte conjugation differs between lymphocyte subpopulations. J Thromb Haemost (2006) 0.81
Influence of acetylcholine, peptides, and other vasodilators on endogenous noradrenaline overflow and vasoconstriction in canine blood perfused gracilis muscle. Acta Physiol Scand (1985) 0.81
Cyclic AMP-dependent and independent inhibition of lipolysis by adenosine and decreased pH. Acta Physiol Scand (1976) 0.80
Inhaled nitric oxide does not influence bleeding time or platelet function in healthy volunteers. Eur J Clin Invest (1999) 0.80